COO Cooper Companies (The)
Updated
Cooper Companies (The) (COO) is a healthcare company in the Ophthalmic Goods industry, with a market capitalization of $13.4 billion. Shares last traded at $70.64, 20.4% below their 52-week high. Over the past year the stock is up 5.2%. COO trades at a price-to-earnings ratio of 23.55, below the Ophthalmic Goods median of 167.20. Net profit margin is 13.5%, above the peer median of 1.1%. Revenue grew 5.1% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. COO split history →
Technicals
Financials
Latest reported annual period ending 2026-07-31 · SEC EDGAR/XBRL.
COO Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2023-10-31 | $3M | $0.02 | 1% |
| 2022-10-31 | $3M | $0.02 | 1% |
| 2021-10-31 | $3M | $0.06 | 0% |
| 2020-10-31 | $3M | $0.06 | 1% |
| 2019-10-31 | $3M | $0.06 | 1% |
| 2018-10-31 | $3M | $0.06 | 2% |
| 2017-10-31 | $3M | $0.06 | 1% |
| 2016-10-31 | $3M | $0.06 | 1% |
| 2015-10-31 | $3M | $0.06 | 1% |
| 2014-10-31 | $3M | $0.06 | 1% |
| 2013-10-31 | $3M | $0.06 | 1% |
| 2012-10-31 | $3M | $0.06 | 1% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $2.49 | 2026-09-09 |
| Q2 2026 | $0.27 | 2026-06-05 |
| Q1 2026 | $0.66 | 2026-03-06 |
| FY 2025 | $1.87 | 2025-12-05 |
| Q3 2026 | $1.45 | 2026-09-09 |
| Q2 2026 | $0.96 | 2026-06-05 |
Ophthalmic Goods peers
COO vs 9 industry peers (Ophthalmic Goods), by market cap. Updated
| COO | Cooper Companies (The) | $13.4B | 23.55 | 3.17 | 13.5% | +1.31% |
| BLCO | Bausch & Lomb Corp | $6.5B | -37.89 | 1.22 | -3.2% | +0.72% |
| WRBY | Warby Parker Inc. | $2.9B | 372.01 | 3.16 | 0.8% | -2.65% |
| EYE | National Vision Holdings, Inc. | $1.3B | 26.53 | 0.66 | 2.5% | +0.42% |
| STAA | Staar Surgical Co | $1.2B | 307.86 | 3.48 | 1.1% | +1.90% |
| RXST | Rxsight, Inc. | $272M | -5.79 | 2.24 | -38.8% | -7.24% |
| LUCY | Innovative Eyewear Inc | $8M | -1.02 | — | — | -2.08% |
| ALC | Alcon Inc | — | — | — | 30.8% | -0.21% |
| LUCYW | Innovative Eyewear Inc | — | — | — | — | -2.96% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.